Literature DB >> 1906087

Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages.

S M Rankin1, S Parthasarathy, D Steinberg.   

Abstract

It has been suggested that the oxidative modification of low density lipoprotein (LDL) is a key event in atherogenesis. Several mechanisms have been proposed to explain how different types of cells modify LDL. In this study we examine the relative contributions of superoxide anions and cellular lipoxygenase (LO) in the modification of LDL by macrophages. Superoxide dismutase (SOD) inhibited LDL oxidation by macrophages but only by 25%. Under the same conditions, several LO inhibitors (eicosatetraynoic acid (ETYA), piriprost, and A-64077) almost completely inhibited the modification of LDL by macrophages. SOD had a greater inhibitory effect on the modification of LDL by U937 cells and fibroblasts (32% and 64%, respectively) but again LO inhibitors had a much greater effect (79 to 100% inhibition). Incubation of [1-14C]linoleic acid with mouse peritoneal macrophages resulted in its conversion to a single more polar product coeluting with 13- and 9-HODE by reverse phase HPLC. When the cells were preincubated with LO inhibitors, formation of this product was significantly inhibited. It is concluded that the modification of LDL by macrophages is mediated in large part by lipoxygenase-type activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906087

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine.

Authors:  Patrick M Hutchins; Robert C Murphy
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

Review 2.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

3.  Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.

Authors:  C P Sparrow; J Olszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 4.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions.

Authors:  S L Hazen; J P Gaut; J R Crowley; F F Hsu; J W Heinecke
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 6.  Atherosclerosis: the eicosanoid connection.

Authors:  A N Makheja
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

7.  Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice.

Authors:  Cinzia M Chinnici; Yuemang Yao; Tao Ding; Colin D Funk; Domenico Praticò
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 8.  Role of oxidised low density lipoprotein in atherogenesis.

Authors:  J L Witztum
Journal:  Br Heart J       Date:  1993-01

Review 9.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

10.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.